ArticleJournal for immunotherapy of cancer2023

Divergent tumor and immune cell reprogramming underlying immunotherapy response and immune-related adverse events in lung squamous cell carcinoma.

Minjiang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.